Lung penetration, bronchopulmonary pharmacokinetic/pharmacodynamic profile and safety of 3 g of ceftolozane/tazobactam administered to ventilated, critically ill patients with pneumoniaLuzelena Caro, Elizabeth G. Rhee, David P. Nicolau et al.|Journal of Antimicrobial Chemotherapy|2020Cited by 67
Pharmacokinetics and Pharmacodynamics of Ceftolozane/Tazobactam in Critically Ill Patients With Augmented Renal ClearanceDavid P. Nicolau, Matthew L. Rizk, Elizabeth G. Rhee et al.|International Journal of Antimicrobial Agents|2021Cited by 34
P-1251. Pharmacometric Analyses to Support Dose Selection of Zoliflodacin, a First-in-Class Oral Antibiotic Being Developed for the Treatment of Uncomplicated GonorrheaSujata M. Bhavnani, Christopher M. Rubino, Anthony P Cammarata et al.|Open Forum Infectious Diseases|2025Cited by 4
Evaluation of Drug–Drug Interaction Potential Between the Oral Antibiotic Zoliflodacin and the <scp>CYP3A4</scp> Inhibitor Itraconazole: A Phase 1 Study in Healthy ParticipantsAlison Luckey, Jean-Yves Gillon, Kajal Larson et al.|Clinical and Translational Science|2026Cited by 0